Twist PUBLIC | NASDAQ:TWST Scale production of synthetic DNA for biological applications, with potential for data storage https://www.twistbioscience.com/ Press Releases Twist Bioscience Partners with Vanderbilt University Medical Center to Supply Critical Products and Identify Antibody Therapeutics for COVID-19 Mar 26, 2020 Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Feb 24, 2020 Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Market Jan 27, 2020 Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery Jan 15, 2020 Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration Dec 29, 2019 GRAIL Appoints Gautam Kollu as Chief Commercial Officer Dec 16, 2019 Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration Dec 11, 2019 Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results Dec 11, 2019 Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery Nov 8, 2019 Twist Bioscience Launches Long Oligos to Fuel Drug Development, DNA Data Storage and Gene Editing Research Jul 29, 2019 « Older Entries Press Coverage FierceBiotech: Ray Tabibiazar departs Aravive to head up development at Twist Bioscience Oct 28, 2018 Hacker Noon: Top 5 Technology advancements Oct 24, 2018 San Francisco Chronicle: ‘Made-to-order’ DNA firm Twist Bioscience plans to go public Oct 8, 2018 Phys.org: Lunar library to include photos, books stored in DNA Sep 28, 2018 SynBioBeta: How CRISPR Is Fighting Breast Cancer Sep 25, 2018 Quartz at Work: The Founders Index: A rising generation of female entrepreneurs in the US Sep 12, 2018 SynBioBeta: From cell culture to table culture: Food tech comes alive Jun 26, 2018 WIRED: The Rise of the DNA Data Storage Jun 26, 2018 GenomeWeb: New Products Posted to GenomeWeb: Thermo Fisher Scientific, Twist Bioscience, 10X Genomics, More Jun 22, 2018 Chemical & Engineering News: Synthetic biology could enable bioweapons development Jun 19, 2018 « Older Entries
Twist Bioscience Partners with Vanderbilt University Medical Center to Supply Critical Products and Identify Antibody Therapeutics for COVID-19 Mar 26, 2020
Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Feb 24, 2020
Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Market Jan 27, 2020
Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery Nov 8, 2019
Twist Bioscience Launches Long Oligos to Fuel Drug Development, DNA Data Storage and Gene Editing Research Jul 29, 2019
FierceBiotech: Ray Tabibiazar departs Aravive to head up development at Twist Bioscience Oct 28, 2018
Quartz at Work: The Founders Index: A rising generation of female entrepreneurs in the US Sep 12, 2018
GenomeWeb: New Products Posted to GenomeWeb: Thermo Fisher Scientific, Twist Bioscience, 10X Genomics, More Jun 22, 2018
